Search research articles
Contact Us
Filters
Showing results (51-60 of 130) with videos related to
Page
of 13
Sort By:
The Biochemical Journal
|
August 1, 1995
Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase
S Namiranian, Y Naito, V V Kakkar, et al.
Thrombosis and Haemostasis
|
July 29, 1984
Increased prothrombinase binding sites in unstimulated platelets from a protein C deficient patient
M F Scully, V Ellis, E Melissari, et al.
Blood
|
September 1, 1984
Postoperative decrease in protein C and hypercoagulability
E Melissari, M F Scully, V Ellis, et al.
Current Pharmaceutical Design
|
September 11, 2008
The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities
X Lu, D Lu, M F Scully, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|
August 24, 2004
Modulation of integrin-binding selectivity by mutation within the RGD-loop of snake venom proteins: a novel drug development approach
X Lu, D Lu, M F Scully, et al.
The Biochemical Journal
|
September 1, 1988
Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II
M F Scully, V Ellis, N Seno, et al.
Thrombosis Research
|
January 1, 1985
The influence of LMW heparin on the coagulation and fibrinolytic response to surgery
E Melissari, M F Scully, T Paes, et al.
Archives of Biochemistry and Biophysics
|
February 1, 1989
Activation of pro-urokinase by plasmin: non-Michaelian kinetics indicates a mechanism of negative cooperativity
M F Scully, V Ellis, Y Watahiki, et al.
Thrombosis Research
|
September 1, 1985
Severe antigenic deficiency of protein C associated with moderate deficiency of protein C activity
E Melissari, M F Scully, V Ellis, et al.
Current Pharmaceutical Design
|
August 22, 2006
Integrins in drug targeting-RGD templates in toxins
X Lu, D Lu, M F Scully, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 130) with videos related to
Sort By:
Page
of 13
The Biochemical Journal
|
August 1, 1995
Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase
S Namiranian, Y Naito, V V Kakkar, et al.
Thrombosis and Haemostasis
|
July 29, 1984
Increased prothrombinase binding sites in unstimulated platelets from a protein C deficient patient
M F Scully, V Ellis, E Melissari, et al.
Blood
|
September 1, 1984
Postoperative decrease in protein C and hypercoagulability
E Melissari, M F Scully, V Ellis, et al.
Current Pharmaceutical Design
|
September 11, 2008
The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities
X Lu, D Lu, M F Scully, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|
August 24, 2004
Modulation of integrin-binding selectivity by mutation within the RGD-loop of snake venom proteins: a novel drug development approach
X Lu, D Lu, M F Scully, et al.
The Biochemical Journal
|
September 1, 1988
Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II
M F Scully, V Ellis, N Seno, et al.
Thrombosis Research
|
January 1, 1985
The influence of LMW heparin on the coagulation and fibrinolytic response to surgery
E Melissari, M F Scully, T Paes, et al.
Archives of Biochemistry and Biophysics
|
February 1, 1989
Activation of pro-urokinase by plasmin: non-Michaelian kinetics indicates a mechanism of negative cooperativity
M F Scully, V Ellis, Y Watahiki, et al.
Thrombosis Research
|
September 1, 1985
Severe antigenic deficiency of protein C associated with moderate deficiency of protein C activity
E Melissari, M F Scully, V Ellis, et al.
Current Pharmaceutical Design
|
August 22, 2006
Integrins in drug targeting-RGD templates in toxins
X Lu, D Lu, M F Scully, et al.
Page
of 13